复发性肝细胞癌患者的治疗策略:切除及其组合模式

Ya'ning Zhao1, Jun Bai2, Xi Wang2

  • 1Department of Medical Oncology of Baoji Central Hospital, Baoji 721008, Shaanxi Province, China.

Journal of Cancer
|March 18, 2024
PubMed
概括

废除性手术为复发性肝细胞癌 (rHCC) 提供了手术的最小侵入性替代方案,显示了与较少不良影响相似的结果. 新兴的研究探讨了将剥离与向治疗和免疫治疗结合起来,以加强治疗.

相关概念视频

Combination Therapies and Personalized Medicine02:50

Combination Therapies and Personalized Medicine

Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
4.9K
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
7.6K